0000000000642450

AUTHOR

D. Caramazza

showing 3 related works from this author

Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome

2010

AdultMaleSalvage TherapyAdolescentPurpura Thrombotic ThrombocytopenicADAMTS13 ProteinCase ReportMiddle AgedADAM ProteinsAntibodies Monoclonal Murine-DerivedTreatment OutcomeHumansImmunologic FactorsFemaleRituximabrefractory thrombotic thrombocytopenic purpura
researchProduct

Trisomy 11: prevalence among 22 403 unique patient cytogenetic studies and clinical correlates.

2010

LEUKEMIA cytogenteic
researchProduct

Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.

2010

thrombotic thrombocytopenic purpura rituximab
researchProduct